Fressia Pharmaceuticals Private Limited

Fressia Pharmaceuticals Private Limited - trading in Dholpur, Rajasthan, India. FY 2026 financials & compliance.
CIN U24232RJ2015PTC047945 Incorporated 24 July 2015 ROC Jaipur HQ Dholpur, Rajasthan, India
Active Private Limited Company trading
Revenue · FY 2025
₹4.17 Lakh
▲ 52% YoY
Net loss · FY 2025
₹865
Net margin -0.2%
EBITDA · FY 2025
₹68
EBITDA margin 0%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
11 yrs
Est. 2015
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Fressia Pharmaceuticals Private Limited

Data last updated:

Fressia Pharmaceuticals Private Limited is a private limited company based in Dholpur, Rajasthan, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 24 July 2015 and has been in existence for over 11 years.

The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24232RJ2015PTC047945. Its GSTIN is 08AACCF6185A1ZT (Rajasthan).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Amit Upadhyay and Raj Tyagi Kumar.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ummedi Nagar Near Rajakhera Bypass, Dholpur, Rajasthan, India – 328001.

As per the financials filed for FY 2025, the company reported a revenue of ₹4.17 Lakh, a growth of 52% compared to the previous year. For the same year it recorded a net loss of ₹865 (net margin -0.2%) and EBITDA of ₹68 (EBITDA margin 0%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years and 1% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24232RJ2015PTC047945
Registration Number 047945
Incorporation Date 24 July 2015
ROC Jaipur
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Fressia Pharmaceuticals Private Limited's registered office is in Dholpur, Rajasthan. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Ummedi Nagar Near Rajakhera Bypass, Dholpur, Rajasthan, India – 328001
  • Industry
    Trading, Other Wholesale, Wholesale

To see the full contact details of Fressia Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Fressia Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Fressia Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Fressia Pharmaceuticals Private Limited, buy the company report.

Financials of Fressia Pharmaceuticals Private Limited

FY 2025 filings available

Fressia Pharmaceuticals Private Limited reported revenue of ₹4.17 Lakh (up 52% YoY) for FY 2025.

Revenue · FY 2025
₹4.17 Lakh ▲ 52%
Net loss · FY 2025
₹865 margin -0.2%
EBITDA · FY 2025
₹68 margin 0%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 52%
3 years · compounded
▲ 24%
5 years · compounded
▲ 1%
EBITDA CAGR growth
1 year
▼ 98%
3 years · compounded
▼ 58%
5 years · compounded
▼ 41%

Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 52% growth in the latest year. EBITDA fell 98% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹68
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹865
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin0%
Net Profit Margin-0.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Fressia Pharmaceuticals Private Limited, buy the company report.

Board of directors of Fressia Pharmaceuticals Private Limited

Fressia Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Amit UpadhyayDirector24 Jul 201511 Years 3 MonthsCurrent
Raj Tyagi KumarDirector24 Jul 201511 Years 3 MonthsCurrent

Peer comparison

Fressia Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Smark Pharmaceuticals Private Limited₹4.23 Lakh (FY 2025)-2.0%Uttar Pradesh, India
Rabindra Pharmaceuticals Private Limited₹4.22 Lakh (FY 2025)-60.0%Muzaffarpur, Bihar, India
Fressia Pharmaceuticals Private Limitedthis company₹4.17 Lakh (FY 2025)-₹865-0.2%52.0%Dholpur, Rajasthan, India
Winsun Pharmaceuticals Private Limited₹4.16 Lakh (FY 2018)8.0%Patna, Bihar, India
Steeford Pharmaceuticals Private Limited₹4.16 Lakh (FY 2025)14.0%Gorakhpur, Uttar Pradesh, India

To see the full peer comparison of Fressia Pharmaceuticals Private Limited, buy the company report.

Auditor

Fressia Pharmaceuticals Private Limited is audited by SANKALP PITALIYA & ASSOCIATES for the financial year 2017.

Auditor firmFinancial yearFirm registration number
SANKALP PITALIYA & ASSOCIATESFY 2017534674

Shareholding

The shareholding of Fressia Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Fressia Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Fressia Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Fressia Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
08AACCF6185A1ZTRajasthanActive01 Jul 2017

To see the full GST registrations and return filing status of Fressia Pharmaceuticals Private Limited, buy the company report.

Recent activity

Fressia Pharmaceuticals Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Amit Upadhyay was appointed as Director on 24 Jul 2015.

AGM
Fressia Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Fressia Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur.
Appointed
Amit Upadhyay was appointed as Director.
Appointed
Raj Tyagi Kumar was appointed as Director.
Incorporation
24 Jul 2015
Fressia Pharmaceuticals Private Limited was registered on 24 Jul 2015 with Roc Jaipur & aged 11 years 3 months as per MCA records.

Frequently asked questions

Fressia Pharmaceuticals is an active private limited company based in Dholpur, Rajasthan, India. The company works in other wholesale, within the trading industry. It was incorporated on 24 July 2015 (11+ years old) and is registered under CIN U24232RJ2015PTC047945.

Fressia Pharmaceuticals has 2 current directors:

The latest financial statements of Fressia Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.

The GSTIN of Fressia Pharmaceuticals is 08AACCF6185A1ZT, registered in Rajasthan.

The CIN (Corporate Identification Number) of Fressia Pharmaceuticals is U24232RJ2015PTC047945. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Fressia Pharmaceuticals was incorporated on 24 July 2015, making it 11+ years old. It is registered with the Registrar of Companies, Jaipur.

The peers of Fressia Pharmaceuticals by revenue are Smark Pharmaceuticals Private Limited, Rabindra Pharmaceuticals Private Limited, Winsun Pharmaceuticals Private Limited, Steeford Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).

Amit Upadhyay was appointed as Director on 24 Jul 2015. Raj Tyagi Kumar was appointed as Director on 24 Jul 2015.

The registered office of Fressia Pharmaceuticals is at Ummedi Nagar Near Rajakhera Bypass, Dholpur, Rajasthan, India – 328001.

Fressia Pharmaceuticals operates in the trading industry, in the other wholesale segment.

The compliance status of Fressia Pharmaceuticals is compliant as of 21 August 2026. The company is actively filing with the Registrar of Companies.